Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever

Key facts

Sponsor

Sheba Medical Center

Principal Investigator

Avi Livneh, professor

Sheba Medical Center, Tel- Hashomer, Ramat- Gan, Israel.

Intervention

Kineret(drug)

Enrollment

25 enrolled

Eligibility

18-65 years · All sexes

Timeline

2012 – 2015

Study locations (1)

• Sheba Medical Center, Ramat Gan, Israel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Familial Mediterranean fever

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07212764
  Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
  Istanbul University
• ENROLLING BY INVITATIONNANCT07013045
  Comparing Structured Neuromuscular Exercise and Exergaming Program in Adolescents With Familial Mediterranean Fever
  Istanbul University - Cerrahpasa
• RECRUITINGNANCT07129538
  Outcomes of Inspiratory Muscle Training in FMF Adolescents
  Cairo University
• RECRUITINGNANCT07130318
  Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise
  Cairo University
• RECRUITINGNANCT07130305
  is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever
  Cairo University
• ACTIVE NOT RECRUITINGNCT07128225
  Health-related Quality of Life, Electrocardiographic and Holter Findings in Children With Familial Mediterranean Fever
  Sohag University
• RECRUITINGNCT06338891
  Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
  University of Palermo
• ACTIVE NOT RECRUITINGNCT06257342
  Physical Abilities of Teenagers With Familial Mediterranean Fever
  Véronique Hentgen

See all trials for Familial Mediterranean fever →